Gene · 1763
Papers1,643
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,643
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA2 Nuclease Inhibition Confers Synthetic Lethality in Cancers with Mutant p53 and Synergizes with PARP Inhibitors. | Cancer Res Commun | 2023 | 37756561 | PubTator, text mining | PubMed |
| Dose-Dependent Shift in Relative Contribution of Homologous Recombination to DNA Repair after Low-LET Ionizing Radiation Exposure: Empirical Evidence and Numerical Simulation. | Curr Issues Mol Biol | 2023 | 37754249 | PubTator, text mining | PubMed |
| Enzyme-Assisted Amplification and Copper Nanocluster Fluorescence Signal-Based Method for miRNA-122 Detection. | Biosensors (Basel) | 2023 | 37754088 | PubTator, text mining | PubMed |
| Short-range end resection requires ATAD5-mediated PCNA unloading for faithful homologous recombination. | Nucleic Acids Res | 2023 | 37739427 | PubTator, text mining | PubMed |
| Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options. | Drugs | 2023 | 37737434 | PubTator, text mining | PubMed |
| The Fanconi anemia core complex promotes CtIP-dependent end-resection to drive homologous recombination at DNA double-strand breaks. | bioRxiv | 2023 | 37732274 | PubTator, text mining | PubMed |
| Genome-wide analysis of DNA-PK-bound MRN cleavage products supports a sequential model of DSB repair pathway choice. | Nat Commun | 2023 | 37717054 | PubTator, text mining | PubMed |
| Inducing multiple nicks promotes interhomolog homologous recombination to correct heterozygous mutations in somatic cells. | Nat Commun | 2023 | 37714828 | PubTator, text mining | PubMed |
| A new wave of innovations within the DNA damage response. | Signal Transduct Target Ther | 2023 | 37679326 | PubTator, text mining | PubMed |
| Structural characterization of human RPA70N association with DNA damage response proteins. | Elife | 2023 | 37668474 | PubTator, text mining | PubMed |
| Centriolar subdistal appendages promote double-strand break repair through homologous recombination. | EMBO Rep | 2023 | 37664992 | PubTator, text mining | PubMed |
| PROCEEDINGS OF THE XXIII CONGRESS OF THE ITALIAN ASSOCIATION OF MYOLOGY: PadovaJune 8-10, 2023. | Acta Myol | 2023 | 37650038 | PubTator, text mining | PubMed |
| Leigh Syndrome Spectrum: A Portuguese Population Cohort in an Evolutionary Genetic Era. | Genes (Basel) | 2023 | 37628588 | PubTator, text mining | PubMed |
| Lysine-Specific Demethylase 4D Is Critical for the Regulation of the Cell Cycle and Antioxidant Capacity in Goat Fibroblast Cells. | Biology (Basel) | 2023 | 37626981 | PubTator, text mining | PubMed |
| The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors. | NAR Cancer | 2023 | 37609662 | PubTator, text mining | PubMed |
| A LoC-SERS platform based on triple signal amplification for highly sensitive detection of colorectal cancer miRNAs. | Anal Methods | 2023 | 37584160 | PubTator, text mining | PubMed |
| Extrachromosomal Telomeres Derived from Excessive Strand Displacements. | bioRxiv | 2023 | 37577643 | PubTator, text mining | PubMed |
| RBM14 promotes DNA end resection during homologous recombination repair. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37559455 | PubTator, text mining | PubMed |
| Research progress on the role and mechanism of DNA damage repair in germ cell development. | Front Endocrinol (Lausanne) | 2023 | 37529603 | PubTator, text mining | PubMed |
| FANCD2 and RAD51 recombinase directly inhibit DNA2 nuclease at stalled replication forks and FANCD2 acts as a novel RAD51 mediator in strand exchange to promote genome stability. | Nucleic Acids Res | 2023 | 37526271 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1763/papers?page=8